Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products

Dongdong Wang1, Yang Yang1, Yingnan Lei1

  • 1The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China (D.W., X.L.); Department of Molecular Biology, Institute of Genetics and Animal Breeding of the Polish Academy of Sciences, Jastrzębiec, Poland (D.W., Y.Y., Y.L., A.G.A.); Department of Pharmacognosy, University of Vienna, Vienna, Austria (A.G.A.); Institute of Clinical Chemistry, University Hospital Zurich, Schlieren, Switzerland (D.W.); Institute of Molecular Biology "Roumen Tsanev," Department of Biochemical Pharmacology and Drug Design, Bulgarian Academy of Sciences, Sofia, Bulgaria (N.T.T.); Pharmaceutical Institute, University of Bonn, Bonn, Germany (N.T.T.); Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester, Rochester, New York (S.X.); Oral and Maxillofacial Radiology, Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China (A.W.K.Y.); and Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria (A.G.A.).

Pharmacological Reviews
|September 27, 2019
PubMed

Insights

Natural products offer potential anti-atherosclerotic effects by targeting foam cell formation. This review explores how these compounds influence lipid uptake, cholesterol esterification, and efflux, crucial processes in atherosclerosis development.

Area of Science:

  • Biochemistry
  • Cardiovascular Biology
  • Pharmacology

Background:

  • Foam cell formation is a key characteristic of atherosclerotic lesions.
  • Targeting foam cell development presents a viable strategy for treating and preventing atherosclerosis.
  • Foam cell formation is regulated by the interplay of lipid uptake, cholesterol esterification, and cholesterol efflux.

Purpose of the Study:

  • To review recent findings on the biologic processes regulating foam cell formation.
  • To summarize natural products with potential to target these processes.
  • To discuss future directions for foam cell-targeted therapeutic strategies.

Main Methods:

  • Literature review of recent scientific findings.
  • Analysis of natural products' effects on lipid metabolism in foam cells.
  • Synthesis of information on anti-atherosclerotic mechanisms.

Main Results:

  • Natural products can inhibit foam cell formation by modulating lipid uptake, cholesterol esterification, and cholesterol efflux.
  • Several natural products demonstrate anti-atherosclerotic capacity through these mechanisms.
  • Understanding these processes is key to developing targeted therapies.

Conclusions:

  • Natural products represent a promising avenue for developing novel anti-atherosclerotic therapies.
  • Targeting the key biologic processes of foam cell formation holds therapeutic potential.
  • Further research into foam cell mechanisms and natural product interactions is warranted.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
61.7K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
933
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
376